Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 47 Lung Neoplasms 23 Carcinoma, Hepatocellular 23 Small Cell Lung Carcinoma 16 Cholangiocarcinoma 10 Breast Neoplasms 10 Urinary Bladder Neoplasms 9 Biliary Tract Neoplasms 9 Neoplasms 8 Neoplasm Metastasis 8 Liver Neoplasms 8 Pancreatic Neoplasms 6 Carcinoma 6 Endometrial Neoplasms 5 Triple Negative Breast Neoplasms 4 Non-Muscle Invasive Bladder Neoplasms 4 Gallbladder Neoplasms 4 Carcinoma, Transitional Cell 4 Ovarian Neoplasms 3 Neoplasms by Site 3 Colorectal Neoplasms 3 Carcinoma, Renal Cell 3 Bile Duct Neoplasms 3 Adenocarcinoma 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Respiratory Tract Neoplasms 2 Pathologic Complete Response 2 Oropharyngeal Neoplasms 2 Neoplasms by Histologic Type 2

Interventions

Gemcitabine 2 Cisplatin 2 durvalumab 1 Simvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Biliary Tract Carcinoma × durvalumab × 90 days × Clear all

NCT07036380 2026-06-01

TACTIC

Centre Hospitalier Universitaire de Besancon

Phase 2 Recruiting

Gastrointestinal

Advanced Biliary Tract Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡